NOS3 and diabetes mellitus: The activation of cPKCβII is increased in aortic endothelial cells of diabetic patients, and PKC inhibitors improved insulin-mediated endothelial nitric oxide synthase (eNOS) activation in patients with diabetes mellitus, which suggested that H2S can regulate the production of eNOS through a certain pathway and participate in the regulation of endothelial function [13].